One of the genes with the most reduced expression in both menopausal status subgroups was tissue inhibitor of metalloproteinases, TIMP3, the silencing of which is consistently associated with cancer progression or poor patient prognosis in multiple human cancers, including EC. The gene discussed is TIMP3; the disease is cancer.